Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front

被引:197
作者
De Wever, Olivier [1 ]
Pauwels, Patrick [2 ]
De Craene, Bram [3 ,4 ]
Sabbah, Michele [5 ]
Emami, Shahin [5 ]
Redeuilh, Gerard [5 ]
Gespach, Christian [5 ,6 ]
Bracke, Marc [1 ]
Berx, Geert [3 ,4 ]
机构
[1] Ghent Univ Hosp, Dept Radiotherapy & Nucl Med, Lab Expt Canc Res, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium
[3] VIB, Dept Mol Biomed Res, Mol & Cellular Oncol Unit, B-9052 Ghent, Belgium
[4] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium
[5] INSERM, U 673, Paris, France
[6] Univ Paris 06, Fac Med, Lab Mol & Clin Oncol Solid Tumors, F-755071 Paris 12, France
关键词
stroma; cadherin; EMT; metastasis; therapy;
D O I
10.1007/s00418-008-0464-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Reduction of epithelial cell-cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial-mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurrence. Furthermore, the tumor stroma dictates EMT through intensive bidirectional communication. The pathological analysis of EMT signatures is critically, especially to determine the presence of cancer cells at the resection margins of a tumor. When diffusion barriers disappear, EMT markers may be detected in sera from cancer patients. The detection of EMT signatures is not only important for diagnosis but can also be exploited to enhance classical chemotherapy treatments. In conclusion, further detailed understanding of the contextual cues and molecular mediators that control EMT will be required in order to develop diagnostic tools and small molecule inhibitors with potential clinical implications.
引用
收藏
页码:481 / 494
页数:14
相关论文
共 165 条
  • [1] Abe A, 1999, ANTICANCER RES, V19, P829
  • [2] Adzic M, 2004, J BUON, V9, P283
  • [3] Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression
    Agiostratidou, Georgia
    Hulit, James
    Phillips, Greg R.
    Hazan, Rachel B.
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2007, 12 (2-3) : 127 - 133
  • [4] The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
    Aigner, K.
    Dampier, B.
    Descovich, L.
    Mikula, M.
    Sultan, A.
    Schreiber, M.
    Mikulits, W.
    Brabletz, T.
    Strand, D.
    Obrist, P.
    Sommergruber, W.
    Schweifer, N.
    Wernitznig, A.
    Beug, H.
    Foisner, R.
    Eger, A.
    [J]. ONCOGENE, 2007, 26 (49) : 6979 - 6988
  • [5] A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis
    Alonso, Soledad R.
    Tracey, Lorraine
    Ortiz, Pablo
    Perez-Gomez, Beatriz
    Palacios, Jose
    Pollan, Marina
    Linares, Juan
    Serrano, Salvio
    Saez-Castillo, Ana I.
    Sanchez, Lydia
    Pajares, Raquel
    Sanchez-Aguilera, Abel
    Artiga, Maria J.
    Piris, Miguel A.
    Rodriguez-Peralto, Jose L.
    [J]. CANCER RESEARCH, 2007, 67 (07) : 3450 - 3460
  • [6] [Anonymous], INT J CANC
  • [7] Detection of serum p53 protein in patients with different gastrointestinal cancers
    Attallah, AM
    Abdel-Aziz, MM
    El-Sayed, AM
    Tabll, AA
    [J]. CANCER DETECTION AND PREVENTION, 2003, 27 (02): : 127 - 131
  • [8] Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment
    Augustine, Christina K.
    Yoshimoto, Yasunori
    Gupta, Mukur
    Zipfel, Patricia A.
    Selim, M. Angelica
    Febbo, Phillip
    Pendergast, Ann Marie
    Peters, William P.
    Tyler, Douglas S.
    [J]. CANCER RESEARCH, 2008, 68 (10) : 3777 - 3784
  • [9] CA 125: The past and the future
    Bast, RC
    Xu, FJ
    Yu, YH
    Barnhill, S
    Zhang, Z
    Mills, GB
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (04) : 179 - 187
  • [10] Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma
    Bates, RC
    Bellovin, DI
    Brown, C
    Maynard, E
    Wu, BY
    Kawakatsu, H
    Sheppard, D
    Oettgen, P
    Mercurio, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 339 - 347